Epic Sciences

Epic Sciences

Epic Sciences

Developing new diagnostic blood tests that can identify and characterize circulating tumor cells to improve cancer detection and to personalize medicine.
Founded
2008
Raised
$150M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$52,000,000
Venture capital (Series E) - 2018
$40,000,000
Venture capital (Series D) - 2017
Domain Associates Genomic Health Sabby Capital +6
Team Size
1–10
Employees
$52,000,000 Venture capital (Series E)
FinSMEs , PE HUB , MedCity News

Epic Sciences Closes $52M in Series E Financing

Health Funding
Xconomy

Epic Sciences Advances Diagnostic for Late-Stage Prostate Cancer

Health Science Funding
$40,000,000 Venture capital (Series D)
PE HUB

Epic Sciences takes in $40 mln Series D

Funding Messaging